Nurse Practitioner Program year 2025 Source: CMS Open Payments, 2026 publication

Sarah Hartmann

Nurse Practitioner, Gerontology Saint Louis, MO Nurse Practitioner

NPI 1881108413 CMS profile 11054944

10012 Kennerly Rd Ste 102, Saint Louis, MO 63128

Open in the dashboard

General payments

$1,665

81 records reported · program year 2025

Research payments

$0

Paid to them · None reported · program year 2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarah Hartmann of Saint Louis, MO is reported in the CMS Open Payments database as having received $1,665 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2025 General $1,665 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Hartmann
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Sarah Hartmann were reported at $1,665. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Sarah Hartmann Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $133 $44–$396 $132
2022 $0 $142 $48–$452 $149
2023 $0 $158 $53–$482 $160
2024 $0 $171 $55–$533 $164
2025 $1,665 $179 $55–$547 $169

Breakdown

Who paid General payments · program year 2025
  1. AbbVie, Inc. $470 22 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $337 19 payments
  3. Madrigal Pharmaceuticals $250 13 payments
  4. Regeneron Healthcare Solutions, Inc. $99 3 payments
  5. Aimmune Therapeutics, Inc. $97 5 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $94 5 payments
  7. Genzyme Corporation $87 2 payments
  8. Ardelyx, Inc. $60 4 payments
  9. Intercept Pharmaceuticals, Inc. $37 2 payments
  10. QOL Medical, LLC $36 2 payments
  11. Other $98 4 payments

Every payment, record by record

What the payments were for General payments · program year 2025
  1. Food and Beverage $1,665 81 payments
Products named General payments · program year 2025
  1. ENTYVIO $291 16 payments
  2. REZDIFFRA $250 13 payments
  3. RINVOQ $249 11 payments
  4. SKYRIZI $249 11 payments
  5. DUPIXENT Immunology And Inflammation $99 3 payments
  6. ZENPEP $97 5 payments
  7. XIFAXAN $94 5 payments
  8. DUPIXENT Immunology $87 2 payments
  9. IBSRELA $60 4 payments
  10. EOHILIA $46 3 payments
  11. Other $260 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 33 drugs

Part D claims

1,023

Median for Nurse Practitioner: 389

Drug cost

$57,996

Median for Nurse Practitioner: $21,885

Branded share of claims

11.8%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mounjaro Tirzepatide Brand 43 $45,531
Duloxetine Hcl Generic 45 $1,482
Rosuvastatin Calcium Generic 86 $1,438
Albuterol Sulfate Hfa Albuterol Sulfate Brand 19 $1,286
Naltrexone Hcl Generic 11 $896
Atorvastatin Calcium Generic 74 $812
Levothyroxine Sodium Generic 71 $725
Gabapentin Generic 35 $676
Bupropion Xl Bupropion Hcl Brand 24 $566
Losartan Potassium Generic 55 $399

The 10 drugs with the highest cost, of 33 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$14,483

Medicare's payments for the services billed

Medicare patients

89

Average age 72

Services billed

266

56 women, 33 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 63%
Arthritis 39%
Diabetes 26%
Depression 24%
Ischemic heart disease 19%
Osteoporosis 17%
Cancer 15%
Atrial fibrillation 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Gerontology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record